Dealmaking Gives Biotechs Needed Financial Relief, But Deal Terms Are Under Pressure
Pharma Partners And Buyers Are In The Driver’s Seat
Biotechs are ready to partner or sell assets to raise cash while turmoil continues in the financial markets, but they are doing so at lower valuations, with IRA and FTC concerns putting further pressure on deal terms.
